Objectives Sleep disturbances and fatigue are common in prostate cancer patients undergoing radiotherapy. Prior research suggests mind-body techniques may improve these outcomes.
| BACKGROUND
Prostate cancer is the most common malignancy in men, with over 220 000 men diagnosed annually in the United States. 1 Radiotherapy is an important curative modality in men with localized prostate cancer and is often combined with androgen deprivation therapy (ADT) in patients with intermediate-or high-risk disease. Both radiotherapy and ADT have significant adverse effects including local toxicities such as bowel, bladder, and erectile dysfunction as well as more systemic effects such as loss of muscle mass, hormonal disruptions, and metabolic syndrome in the case of ADT. 2 Fatigue is the most common complaint of patients undergoing radiotherapy, 3, 4 with a reported incidence of up to 80%, and this can be compounded with ADT. 5 Radiation 6 and ADT 7, 8 and their adverse effects may also result in significant sleep impairments. Fatigue and insomnia can influence quality of life (QOL) as well as physical and social functioning and in many cases become chronic issues impacting survivors. 5, 9 Both aerobic 10, 11 and resistance [12] [13] [14] [15] exercise programs have previously been shown to improve fatigue, physical functioning, and QOL in prostate cancer patients undergoing radiotherapy as well as in patients on ADT. Exercise may also mitigate the impact of ADT on metabolic parameters and muscle loss. 16 
| Qigong/tai chi
Movement-based mind-body practices such as qigong, tai chi, and yoga combine physical postures or movements, focus on the breath, and mindfulness. 17 The ancient Chinese practices of qigong ("qi" energy and "gong" skill) and tai chi ("tai" supreme and "chi" ultimate) originated in martial arts forms, but the movements are slow and gentle, and this low-impact meditative exercise is widely practiced in
China and is becoming increasingly popular in the West. In noncancer populations, qigong/tai chi (QGTC) has been shown to decrease anxiety 18 and improve cognitive function 19 and sleep quality. [20] [21] [22] Previous work in breast cancer patients undergoing radiotherapy has shown that qigong practice can impact depressive symptoms, fatigue, and QOL. 23 A small study recently reported promising results of improvement in fatigue in elderly prostate cancer survivors practicing qigong when compared with those randomized to a stretching intervention. 24 This is consistent with the findings of studies that have investigated the impact of other modalities combining physical movement with meditation, such as yoga, on depressive symptoms, sleep, fatigue, and QOL in cancer patients. [25] [26] [27] [28] [29] The effects of these multifaceted mind-body approaches on sleep and fatigue seem to be in part mediated by stress reduction and control of depression and anxiety. 23, 28 The current study sought to examine the effects of incorporating a 30 In minimization, treatment assignment for each patient is done sequentially to balance covariate characteristics among groups.
In this case, patient characteristics for group assignment included stage, risk group, age, time since diagnosis, timing of radiotherapy, use of ADT, and baseline anxiety score. Follow-up assessments were conducted midway through radiotherapy (abbreviated assessment) (T2), during the last week of radiotherapy (T3), and at 1 (T4) and 3 months (T5) after the end of radiotherapy. Participants were given a gift certificate after completing each assessment ($20 for full assessments and $10 for midtherapy abbreviated assessment). The WLC group completed the same assessments and was given the option of participating in either QGTC or LE classes at the end of all assessments. Patients in the LE and WLC groups were asked to refrain from participating in any QGTC classes for the duration of the study.
| Intervention programs
Patients assigned to the QGTC and LE groups attended three 40-minute classes per week throughout radiotherapy. Classes were conducted oneon-one or with 1 or 2 other patients based on scheduling. However, the vast majority of classes were conducted one-on-one. Patients were given a DVD and printed instructional materials and encouraged to practice up to daily on their own.
| QGTC program
The QGTC classes were taught by a trained qigong master. The program was based on one developed by Dr Jerry Alan Johnson for cancer patients. 31 The program involved (1) preparation exercises (6 minutes)
consisting of guided breathing, the Great Tai Chi Circle to open the energy pathways, and grounding and centering exercises; (2) main exercises (20 minutes) including the classical 8-form Yang style tai chi, which is designed to take each major muscle system and joint through a range of motion, and qigong forms specifically designed to reduce the adverse effects of cancer therapy through gentle movements 31 ;
and (3) ending exercises (9 minutes) including the tai chi ball form to rebalance energy, the pat down form to remove unwanted energies, and standing meditation to quiet the mind.
| LE program
An exercise physiologist led the LE classes. The program was focused on light resistance training and stretching exercises with a goal of maintaining muscle strength and range of motion. The level of exertion and movement was designed to match that of the QGTC group and provide an active control that also controls for attention and other nonspecific effects. Resistance training employed a combination of 3 levels of resistance tubes, and the focus is on lighter tension and more repetition (8-12 per set). Each participant was prescribed tailored resistance exercises using a combination of the 3 tubes targeting 8 to 12
repetitions per set. Participants were given individualized prescriptions based on baseline abilities detailing specific exercises for each day of the week, with muscle groups varying by day. Stretching exercises focused on major joints and were aligned with the muscle group being targeted by resistance training.
| Outcome measures
Patients completed a number of psychosocial questionnaires, and here we report on the 2 primary outcome measures (sleep and fatigue) and health-related QOL as an exploratory outcome.
Sleep disturbances were assessed using the Pittsburgh Sleep
Quality Index (PSQI), 32 an 18-item self-rated questionnaire that assesses quality of sleep and sleep disturbances over the past 1 month.
A total score is derived, as well as 7 subscales: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. Higher scores represent greater sleep disturbances.
Fatigue was assessed using the Brief Fatigue Inventory, 33 a 9-item questionnaire that asks participants to rate the severity of their fatigue at that moment and how much their fatigue has interfered with their lives over the previous 24 hours. Higher scores represent more fatigue. was not included in the primary analysis (Figure 1 ). Baseline characteristics of the participants assigned to each intervention were analyzed using chi-square tests for categorical variables and t tests for continuous variables. There were no significant differences in demographic or medical characteristics between groups (Table 1) . However, the LE group reported greater sleep time at baseline than the other 2 groups (QGTC 6.2 vs LE 7.1 vs WLC 6.5, P = .04) ( Table 2 and Figure 2 ). Eighty percent of the participants were white, with a mean age of 64.5 years.
| Health-related QOL

| Completion of interventions
Adherence to the interventions was high, with 63.5% attending all sessions and 80.8% attending greater than 50% of the sessions. There were no differences between the QGTC and LE groups in class attendance.
| Main effects of interventions
There was a statistically significant effect of time on sleep duration (F = 2.63, P = .03), with an increase in sleep duration over time. Similarly, there was a significant time main effect for sleep efficiency, with improvements over time (F = 2.77, P = .028). In the mixed-model analysis with repeated measures, there was no significant treatment main effect and there was a marginal group-by-time interaction for sleep duration (F = 2.07, P = .06). Post hoc analyses from the mixed model revealed that at T2 (midway through radiotherapy) the QGTC group slept significantly longer than those in the LE group (QGTC 7.00 h vs LE 6.45 h, P = .047; d = 0.56) and marginally significantly longer than the WLC group (WLC 6.53 h, P = .07; d = 0.51) ( Table 2 and Figure 2 ). However, this difference did not persist to the end of radiotherapy, and there were also no group differences in sleep duration at the follow-up time points. No significant group, or group-by-time, interactions were observed for the other sleep outcomes, and all effect sizes were in the small range (d < 0.45) ( Table 2 ). Pittsburgh Sleep Quality Index total scores were slightly above 5 for each group at each time point, indicating clinically significant sleep disturbance. There was a main effect of time on fatigue (F = 3.79, P = .005), with increases over time. There were no significant group or groupby-time interactions for fatigue levels. However, fatigue remained in the "mild" range (≤3) in all groups at all time points.
32
Although there were no group differences between patients with and without missing data on demographic, medical, or outcome variables at baseline, we imputed the missing data using multiple imputations (SAS V9.2 MI procedure) with the Markov chain Monte
Carlo method and then used the MIANALYZE procedure to generate statistical inferences. All the analyses resulted in similar P values.
| Exploratory analyses
Because of the lack of group differences for both sleep outcomes and fatigue levels, we sought to explore factors that were associated with both variables to explore potential factors interfering with the effects of the intervention. We examined health-related QOL as assessed from the EPIC. We first sought to determine if there were any group differences on these measures. Mixed-model analysis revealed no group differences on any of these variables at each time point. However, not surprisingly, urinary function, bowel function, and prostate symptom score (American Urological Association [AUA] symptom score) were all significantly worse by the end of radiotherapy and improved by the 1-and 3-month follow-ups (Table 3) . There was no effect of time on hormonal function.
Exploratory analyses were then conducted to examine the effect of prostate cancer health-related QOL (EPIC) and prostate-related symptoms (AUA symptom score) on sleep and fatigue at each time point. We found significant and consistent correlations between sleep and fatigue with urinary, bowel, and hormonal functions and AUA symptom scores (Table 4 ). Table 4 indicates that worse prostate cancer health-related QOL was associated with greater sleep disturbance and fatigue scores.
| CONCLUSIONS
In this study, we found that a QGTC intervention during radiation for prostate cancer resulted in statistically superior self-reported sleep duration of a moderate effect size compared with both WLC and a supervised LE intervention midway through radiation but that this effect was not durable. Moreover, the clinical significance of an improvement in self-reported sleep duration from 6.4 to 7 hours is unclear, although 7 hours of sleep is the minimum recommended in many guidelines 35 based on data showing shorter sleep duration is associated with disease risk in many populations. 36, 37 Sleep duration of all 3 groups returned to baseline levels or in fact higher at subsequent time points, although the composite PSQI score remained above the clinical threshold for "sleep disturbance" for all groups at all time points other than the LE group at end of radiation. Within our limited sample, we did not detect any group differences in other domains of in this population, although it did increase with time, was surprisingly mild.
The lack of detected durable benefit of the QGTC intervention on improving sleep and fatigue in this population is likely driven by the fact that both sleep disturbances and fatigue in prostate cancer are mainly due to hot flashes and/or urinary symptoms, which were not modified with the intervention. 7, 8, 38 Although there were group differences midway through radiotherapy, all 3 groups returned to baseline levels or in fact higher than baseline at subsequent time points. This suggests that the negative effects of radiotherapy on sleep duration are short term and that QGTC may be protective against these changes.
Indeed, in our study, urinary, bowel, and hormonal disturbances were reduced by the end of radiotherapy and significantly and consis- Unlike previous studies, 12,13 we also did not find a difference in sleep and fatigue between the LE and control groups. The exercise intervention in this study was designed to match the intensity of the QGTC intervention and thus differed from other exercise interventions and may not have met the threshold for benefit.
The feasibility of conducting a mind-body intervention in a prostate cancer population undergoing radiotherapy was demonstrated, although the acceptance rate was less than 50% and the trial was terminated early for slow recruitment. Participants in the QGTC arm shared that they found the classes enjoyable and beneficial, noting relaxation, stress reduction, and improved balance as benefits. The vast majority of mind-body intervention trials have been conducted in the breast cancer population, with a majority during the survivorship phase. This is likely a reflection of the higher intrinsic interest in and self-adoption of complementary medicine including mind-body approaches by younger breast cancer patients, a trend observed in multiple prior survey studies of complementary and alternative medicine use in cancer patients. 42, 43 Our study has several limitations, which must be acknowledged.
Given that the sample size did not reach our target, we were underpowered to detect small differences in fatigue and sleep between groups and the attrition from randomization to the 3-month followup significantly reduced power. However, no consistent trends were observed towards superiority of the QGTC intervention group and small differences are likely not clinically meaningful. The majority of patients also did not complete the assessments asking about frequency of home practice. This may have been due to the patients not engaging in the practices after the end of radiotherapy, a common occurrence in mind-body research. Future studies need to more effectively collect home practice data and develop strategies to increase adherence.
While the PSQI is a well-validated patient-reported measure of sleep disturbances, it is a measure of self-reported sleep habits over a 1-month period, and given that these patients were on active treatment, sleep may not have been highly homogenous over that 1-month period. Furthermore, self-reported sleep and actual sleep duration measured by actigraphy have been found to be only modestly correlated in past studies. 44 Future studies should incorporate actigraphy as an objective sleep quality measure; however, selfreported sleep remains an important end point as a measure of satisfaction with sleep. As always, the inclusion of appropriate controls, as was done in this study, which included active controls and WLCs, is critical in research of self-reported outcomes.
In conclusion, we found that a QGTC intervention during radiation for prostate cancer resulted in statistically improved self-reported duration of sleep at mind radiotherapy compared with both LE and WLC groups but that this effect was not sustained and other sleep and fatigue domains were not significantly improved. In this population, urinary and hormonal symptoms appear to drive sleep disturbances and QGTC did not modify these outcomes. Future mind-body intervention studies in this population should include multimodal therapy to address physical symptoms the men are experiencing. 
